Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of two botulinum toxin type A products for moderate to severe forehead wrinkles
2009-010338-23Phase 2Completed
- Sponsor
- Galderma
- Start
- Apr 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial of botulinum toxin type A in wrinkly skin syndrome (WSS) and Forehead lines (2 arms), sponsored by Galderma. Primary endpoint: Primary efficacy. Started Apr 2009; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
wrinkly skin syndrome (WSS)Forehead lines
Beyond the preview
Go deeper on 2009-010338-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010338-23.